CEACAM5 and cancer: Ti3C2 SMQDs that are monolayer- or multilayer-coated with an acceptor amino group for covalently immobilizing the carcinoembryonic monoclonal antibody for cancer biomarker detection are the first SMQDs-based CEA detectors.